文献速递心境障碍精神分裂症与精神病性障碍

重性抑郁障碍、双相障碍和精神分裂症观察性研究中肠道微生物群组成的系统综述

A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia.
PubMed 文献 · Mol Psychiatry · 2022-02-22

该系统综述遵循PRISMA指南检索至2021年12月,纳入44项研究(2510例精神疾病患者和2407例对照),比较重性抑郁障碍、双相障碍和精神分裂症患者与健康对照的肠道微生物群组成;合成分析未发现α多样性差异的强证据,但β多样性差异较一致,并识别出与精神疾病相关的特定细菌分类群。

要点

  • 纳入44项研究(2510例患者、2407例对照),其中重性抑郁障碍24项、双相障碍7项、精神分裂症15项。
  • 未发现精神障碍患者与对照间细菌数量或分布(α多样性)差异的强证据。
  • 研究较一致报告整体群落组成(β多样性)差异,并识别出产短链脂肪酸细菌较低等特定分类群。

核心结论

  • 合成分析未提供精神障碍患者与对照间细菌数量或分布(α多样性)差异的强证据,但研究较一致报告整体群落组成(β多样性)差异。
  • 识别出与精神障碍 commonly 相关的特定细菌分类群,包括产短链脂肪酸(如丁酸)的细菌属水平较低、产乳酸细菌水平较高、与谷氨酸和GABA代谢相关的细菌水平较高。
  • 研究间在方法和报告方面存在显著异质性。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索数据库自建库至2021年12月。
  • 纳入44项研究,共2510例精神疾病患者和2407例对照;其中重性抑郁障碍24项、双相障碍7项、精神分裂症15项。

主要发现

  • 未发现精神障碍患者与对照间细菌数量或分布(α多样性)差异的强证据。
  • 研究较一致报告精神障碍患者与无精神障碍者之间整体群落组成(β多样性)存在差异。
  • 识别出与精神障碍 commonly 相关的特定细菌分类群:产短链脂肪酸(如丁酸)的细菌属水平较低、产乳酸细菌水平较高、与谷氨酸和GABA代谢相关的细菌水平较高。
  • 研究间在方法和报告方面存在显著异质性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究间在方法和报告方面存在显著异质性。
  • 需进一步开展使用新工具和稳健指南的前瞻性和实验性研究,以增进对肠道微生物群在精神和大脑健康中作用的理解及开发基于调节肠道微生物群的干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The emerging understanding of gut microbiota as 'metabolic machinery' influencing many aspects of physiology has gained substantial attention in the field of psychiatry. This is largely due to the many overlapping pathophysiological mechanisms associated with both the potential functionality of the gut microbiota and the biological mechanisms thought to be underpinning mental disorders. In this systematic review, we synthesised the current literature investigating differences in gut microbiota composition in people with the major psychiatric disorders, major depressive disorder (MDD), bipolar disorder (BD) and schizophrenia (SZ), compared to 'healthy' controls. We also explored gut microbiota composition across disorders in an attempt to elucidate potential commonalities in the microbial signatures associated with these mental disorders. Following the PRISMA guidelines, databases were searched from inception through to December 2021. We identified 44 studies (including a total of 2510 psychiatric cases and 2407 controls) that met inclusion criteria, of which 24 investigated gut microbiota composition in MDD, seven investigated gut microbiota composition in BD, and 15 investigated gut microbiota composition in SZ. Our syntheses provide no strong evidence for a difference in the number or distribution (α-diversity) of bacteria in those with a mental disorder compared to controls. However, studies were relatively consistent in reporting differences in overall community composition (β-diversity) in people with and without mental disorders. Our syntheses also identified specific bacterial taxa commonly associated with mental disorders, including lower levels of bacterial genera that produce short-chain fatty acids (e.g. butyrate), higher levels of lactic acid-producing bacteria, and higher levels of bacteria associated with glutamate and GABA metabolism. We also observed substantial heterogeneity across studies with regards to methodologies and reporting. Further prospective and experimental research using new tools and robust guidelines hold promise for improving our understanding of the role of the gut microbiota in mental and brain health and the development of interventions based on modification of gut microbiota.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. McGuinness AJ, Davis JA, Dawson SL, et al. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry. 2022. PMID: 35194166. doi:10.1038/s41380-022-01456-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。